Russell Investments Group’s Dr. Reddy's Laboratories RDY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $67.9K | Buy |
4,902
+1,811
| +59% | +$25.2K | ﹤0.01% | 3209 |
|
|
2025
Q4 | $43.4K | Buy |
3,091
+2,749
| +804% | +$38.6K | ﹤0.01% | 3354 |
|
|
2025
Q3 | $4.78K | Sell |
342
-34
| -9% | -$489 | ﹤0.01% | 3907 |
|
|
2025
Q2 | $5.65K | Buy |
376
+13
| +4% | +$186 | ﹤0.01% | 3424 |
|
|
2025
Q1 | $4.79K | Sell |
363
-169,357
| -100% | -$2.34M | ﹤0.01% | 3374 |
|
|
2024
Q4 | $2.68M | Sell |
169,720
-33,940
| -17% | -$510K | ﹤0.01% | 1510 |
|
|
2024
Q3 | $3.24M | Sell |
203,660
-91,160
| -31% | -$1.47M | ﹤0.01% | 1427 |
|
|
2024
Q2 | $4.49M | Sell |
294,820
-236,605
| -45% | -$3.39M | 0.01% | 1200 |
|
|
2024
Q1 | $7.8M | Sell |
531,425
-49,790
| -9% | -$727K | 0.01% | 947 |
|
|
2023
Q4 | $8.09M | Buy |
581,215
+51,600
| +10% | +$690K | 0.01% | 893 |
|
|
2023
Q3 | $7.08M | Buy |
529,615
+500,135
| +1,697% | +$6.77M | 0.01% | 912 |
|
|
2023
Q2 | $372K | Buy |
29,480
+12,380
| +72% | +$145K | ﹤0.01% | 2316 |
|
|
2023
Q1 | $195K | Hold |
17,100
| – | – | ﹤0.01% | 2482 |
|
|
2022
Q4 | $177K | Hold |
17,100
| – | – | ﹤0.01% | 2593 |
|
|
2022
Q3 | $179K | Hold |
17,100
| – | – | ﹤0.01% | 2568 |
|
|
2022
Q2 | $189K | Hold |
17,100
| – | – | ﹤0.01% | 2554 |
|
|
2022
Q1 | $190K | Hold |
17,100
| – | – | ﹤0.01% | 2470 |
|
|
2021
Q4 | $223K | Hold |
17,100
| – | – | ﹤0.01% | 2693 |
|
|
2021
Q3 | $222K | Hold |
17,100
| – | – | ﹤0.01% | 2748 |
|
|
2021
Q2 | $251K | Hold |
17,100
| – | – | ﹤0.01% | 2833 |
|
|
2021
Q1 | $209K | Sell |
17,100
-77,295
| -82% | -$993K | ﹤0.01% | 2813 |
|
|
2020
Q4 | $1.34M | Hold |
94,395
| – | – | ﹤0.01% | 1971 |
|
|
2020
Q3 | $1.3M | Hold |
94,395
| – | – | ﹤0.01% | 1933 |
|
|
2020
Q2 | $1M | Buy |
94,395
+51,160
| +118% | +$520K | ﹤0.01% | 2056 |
|
|
2020
Q1 | $347K | Buy |
43,235
+28,000
| +184% | +$233K | ﹤0.01% | 2334 |
|
|
2019
Q4 | $124K | Hold |
15,235
| – | – | ﹤0.01% | 2840 |
|
|
2019
Q3 | $119K | Sell |
15,235
-34,500
| -69% | -$257K | ﹤0.01% | 2781 |
|
|
2019
Q2 | $375K | Hold |
49,735
| – | – | ﹤0.01% | 2355 |
|
|
2019
Q1 | $395K | Buy |
49,735
+15,235
| +44% | +$116K | ﹤0.01% | 2418 |
|
|
2018
Q4 | $260K | Buy |
+34,500
| New | +$243K | ﹤0.01% | 2529 |
|
|
2018
Q3 | – | Sell |
-10,620
| Closed | -$69K | – | 3007 |
|
|
2018
Q2 | $69K | Sell |
10,620
-8,825
| -45% | -$55.7K | ﹤0.01% | 2777 |
|
|
2018
Q1 | $127K | Sell |
19,445
-43,695
| -69% | -$306K | ﹤0.01% | 2721 |
|
|
2017
Q4 | $470K | Sell |
63,140
-100,815
| -61% | -$726K | ﹤0.01% | 2452 |
|
|
2017
Q3 | $1.17M | Hold |
163,955
| – | – | ﹤0.01% | 2062 |
|
|
2017
Q2 | $1.38M | Sell |
163,955
-109,175
| -40% | -$888K | ﹤0.01% | 1955 |
|
|
2017
Q1 | $2.19M | Buy |
273,130
+135,945
| +99% | +$1.17M | ﹤0.01% | 1704 |
|
|
2016
Q4 | $1.23M | Buy |
+137,185
| New | +$1.28M | ﹤0.01% | 2077 |
|
Other funds holding RDY
AIM
Russell Investments Group's RDY Position: Q1 2026 in Review
Russell Investments Group increased its Dr. Reddy's Laboratories (RDY) stake by 59% in Q1 2026, buying an estimated $25.2K and bringing the position to 4,902 shares worth $67.9K. The position accounts for ﹤0.01% of the portfolio, ranked #3209.
Russell Investments Group first reported a position in RDY in Q4 2016 and has held it in 37 quarters since. The position peaked at $8.09M in Q4 2023. 247 funds tracked by Wall St. Rank hold RDY as of Q1 2026.
- Russell Investments Group held 4,902 shares of Dr. Reddy's Laboratories worth $67.9K as of Q1 2026.
- Russell Investments Group bought 1,811 Dr. Reddy's Laboratories shares in Q1 2026, an estimated $25.2K.
- Dr. Reddy's Laboratories made up ﹤0.01% of Russell Investments Group's portfolio in Q1 2026, its #3209 holding.
- Russell Investments Group first reported a position in Dr. Reddy's Laboratories in Q4 2016 and has held it in 37 quarters since.
- Russell Investments Group's Dr. Reddy's Laboratories position peaked at $8.09M in Q4 2023.
- 247 funds tracked by Wall St. Rank held Dr. Reddy's Laboratories as of Q1 2026.
Based on Russell Investments Group's 13F filing for Q1 2026, filed 8 May 2026.